Table 8.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1992 to 2001

Recipients with Kidney-Pancreas Transplants

		Year of Transplant
		1992	1993	1994	1995	1996	1997	1998	1999	2000	2001
Transplants		493	661	748	919	860	853	972	941	914	891
Tx With Follow-up Immunosuppression Info		431	585	649	836	784	788	887	872	849	817
Corticosteroids	Category Usage	100.0%	99.8%	100.0%	99.8%	99.6%	99.6%	99.5%	99.1%	95.5%	91.9%
	Steroids	100.0%	99.8%	100.0%	99.8%	99.6%	99.6%	99.5%	99.1%	95.5%	91.9%
Cyclosporine	Category Usage	99.8%	98.1%	82.0%	64.8%	58.3%	45.9%	33.3%	28.1%	21.3%	15.9%
	Cyclosporin	99.1%	96.8%	78.9%	32.2%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	2.3%	5.3%	7.2%	25.1%	8.4%	6.1%	2.8%	3.9%	2.4%	1.6%
	Neoral	0.0%	0.7%	0.8%	35.3%	54.3%	42.3%	31.8%	26.1%	18.5%	11.8%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	2.0%	3.3%
	Eon	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.4%
Tacrolimus	Category Usage	0.5%	3.1%	26.2%	44.0%	48.6%	60.0%	73.8%	79.4%	83.6%	88.7%
	FK506	0.5%	3.1%	26.2%	44.0%	48.6%	60.0%	73.8%	79.4%	83.6%	88.7%
Antimetabolites	Category Usage	98.8%	96.8%	90.9%	69.7%	72.8%	92.9%	95.9%	94.8%	86.1%	78.9%
	Azathioprine	98.8%	96.8%	90.4%	53.0%	19.8%	11.4%	9.2%	7.0%	5.1%	2.4%
	Mycophenolate mofetil	0.0%	0.2%	1.8%	21.2%	58.4%	87.1%	91.9%	91.5%	83.6%	78.1%
Other	Category Usage	0.5%	0.2%	0.6%	0.7%	0.0%	0.1%	0.8%	4.1%	18.1%	27.3%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.6%	4.1%	17.9%	27.3%
	Cytoxan	0.5%	0.2%	0.6%	0.7%	0.0%	0.1%	0.2%	0.0%	0.2%	0.0%

Source: OPTN/SRTR Data as of August 1, 2003.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.